{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T02:59:56Z","timestamp":1778641196734,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["JA Clin Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 52-year-old female was diagnosed with tongue cancer and scheduled for partial glossectomy. Preoperative examinations revealed Child-Pugh C liver cirrhosis, but the pathogenesis was unknown. We scheduled remimazolam anesthesia because it would stabilize her intraoperative circulation. We managed with a much lower-than-normal dose of remimazolam; even so, the patient required flumazenil to regain consciousness. She was admitted to the intensive care unit, but her consciousness remained clear even after the effect of flumazenil had worn off.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We experienced anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis. Even conservative use of remimazolam in patients with severe hepatic dysfunction may result in emergence times that are delayed longer than expected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40981-022-00590-9","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T01:02:33Z","timestamp":1672102953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2906-7749","authenticated-orcid":false,"given":"Satoshi","family":"Uchida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Takekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Hashiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"key":"590_CR1","first-page":"543-53","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34:543-53.","journal-title":"J Anesth."},{"key":"590_CR2","first-page":"A1611","volume":"105","author":"ST Gary","year":"2006","unstructured":"Gary ST, Gavine K. CNS 7056X, an ultra-short acting benzodiazepine: in vitro metabolism. Anesthesiology. 2006;105:A1611.","journal-title":"Anesthesiology."},{"key":"590_CR3","first-page":"9268454","volume":"2022","author":"A Onoda","year":"2022","unstructured":"Onoda A, Suzuki Y. A new anesthetic, remimazolam, is useful in the management of anesthesia in patients with liver cirrhosis. Case Rep Anesthesiol. 2022;2022:9268454.","journal-title":"Case Rep Anesthesiol."},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/gut.2007.129130","volume":"57","author":"AA Dahaba","year":"2008","unstructured":"Dahaba AA, Worm HC, Zhu SM, et al. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study. Gut. 2008;57:77\u201383.","journal-title":"Gut."},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bja.2021.05.027","volume":"127","author":"T St\u00f6hr","year":"2021","unstructured":"St\u00f6hr T, Colin PJ, Ossig J, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127:415\u201323.","journal-title":"Br J Anaesth."},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG, Sola E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet. 2021;398:1359\u201376.","journal-title":"Lancet."},{"key":"590_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s11605-021-05037-7","volume":"25","author":"LV Selby","year":"2021","unstructured":"Selby LV, Fernandez-Bustamante A, Ejaz A, et al. Association between anesthesia delivered during tumor resection and cancer survival: a systematic review of a mixed picture with constant themes. J Gastrointest Surg. 2021;25:2129\u201341.","journal-title":"J Gastrointest Surg."},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"e20153","DOI":"10.5812\/ircmj.20153","volume":"16","author":"S Safari","year":"2014","unstructured":"Safari S, Motavaf M, Siamdoustet SAS, et al. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J. 2014;16:e20153.","journal-title":"Iran Red Crescent Med J."},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"108331","DOI":"10.1016\/j.intimp.2021.108331","volume":"101","author":"H Fang","year":"2021","unstructured":"Fang H, Zhang Y, Wang J, et al. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages. Int Immunopharmacol. 2021;101:108331.","journal-title":"Int Immunopharmacol."},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1124\/mol.107.036889","volume":"72","author":"J Yang","year":"2007","unstructured":"Yang J, Shi D, Yang D, Song X, Yan B. Interleukin-6 alters the cellular responsiveness to clopidogrel, irinotecan, and oseltamivir by suppressing the expression of carboxylesterases HCE1 and HCE2. Mol Pharmacol. 2007;72:686\u201394.","journal-title":"Mol Pharmacol."},{"key":"590_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003102","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried A, Sch\u00fcttler J, Lerch L, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132:636\u201351.","journal-title":"Anesthesiology"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"e0268568","DOI":"10.1371\/journal.pone.0268568","volume":"17","author":"Y Shimamoto","year":"2022","unstructured":"Shimamoto Y, Sanuki M, Kurita S, et al. Factors affecting prolonged time to extubation in patients given remimazolam. Plos One. 2022;17:e0268568.","journal-title":"Plos One."},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00540-021-02915-x","volume":"35","author":"T Yamamoto","year":"2021","unstructured":"Yamamoto T, Kurabe M, Kamiya Y. Re-sleeping after reversal of remimazolam by flumazenil. J Anesth. 2021;35:322.","journal-title":"J Anesth."}],"container-title":["JA Clinical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40981-022-00590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40981-022-00590-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40981-022-00590-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T05:03:55Z","timestamp":1672376635000},"score":1,"resource":{"primary":{"URL":"https:\/\/jaclinicalreports.springeropen.com\/articles\/10.1186\/s40981-022-00590-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/s40981-022-00590-9","relation":{},"ISSN":["2363-9024"],"issn-type":[{"value":"2363-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]},"assertion":[{"value":"20 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for the publication of this case was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}